Company Filing History:
Years Active: 2011
Title: Marina Pretolani: Innovator in Anti-Inflammatory Treatments
Introduction
Marina Pretolani is a distinguished inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in the development of innovative treatments for inflammatory diseases. Her work is characterized by a strong focus on the use of antibody fragments to target specific receptors in the body.
Latest Patents
Marina holds a patent for a groundbreaking invention titled "Monovalent ligand of the FcαRI receptor as an anti-inflammatory agent." This invention relates to the use of a monovalent antibody fragment directed against the EC2 domain of the FcαRI receptor for the treatment of inflammatory diseases. This patent highlights her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Marina is affiliated with the Institut National de la Santé et de la Recherche Médicale, where she conducts her research. Her work has garnered attention for its potential to revolutionize the treatment of inflammatory conditions, showcasing her expertise and dedication to her field.
Collaborations
Throughout her career, Marina has collaborated with notable colleagues, including Renato Monteiro and Benoît Pasquier. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Marina Pretolani is a remarkable inventor whose work in anti-inflammatory treatments is paving the way for new therapeutic options. Her dedication to research and innovation continues to inspire advancements in medical science.